Study of people newly diagnosed with liver cancer in France
Part of Cancer, Digestive system clinical trials.
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of liver cancer (HCC), or a strong suspicion of HCC
- If you already have HCC, you are currently on medicine to treat recurrence or progression
- Your situation does not include another serious, life-threatening illness that could harm you in the near future (except liver disease itself)
- You are an adult and not under legal protection/guardianship
- You are not currently unable to make decisions due to being deprived of liberty by legal or administrative order
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with bile duct cancer or certain liver cancers to better understand their disease. You might be included if you meet the diagnosis and basic participation requirements.
This study reviews medical records of people diagnosed with hepatocellular carcinoma (liver cancer) between 2015 and 2023 to better understand how the disease progresses and how different treatments work. Your information helps researchers learn what care approaches work best for future patients.
This study looks at how well doctors can detect small, early liver cancer and then follow how it changes over time. It may help your care team choose the best next steps based on earlier, clearer detection.
This trial looks at how to guide people with hepatocellular carcinoma (a type of liver cancer) through the study process. It may help you by explaining what to expect and supporting you in following required study steps.
This trial looks at overall survival (how long people live) in real-world patients with unresectable liver cancer. It may help researchers understand outcomes outside of tightly controlled studies.
This trial aims to discover new immune system targets on liver cancer cells and other tumors to develop better immunotherapies. Researchers will analyze tumor samples to find these targets, which could lead to more effective treatments.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.